Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00952133 · ClinicalTrials.gov registry record · Phase 4
Efficacy of IV Palo With IV Dexamethasone vs IV Palo for Prevention of Immediate & Delayed PONV
A Phase 4 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 118
- Enrollment target
NCT00952133 is a Phase 4 study that has completed, run by NYU Langone Health. The registered enrollment target is 118 participants.
The verdict
NCT00952133, a Phase 4 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 118 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if subjects who receive Palonosetron plus Dexamethasone have less post-operative nausea and vomiting (PONV) than those who receive Palonosetron alone.
Interventions
- DRUG Palonosetron only
- DRUG Palonosetron with Dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00952133
The ClinicalTrials.gov registry entry for NCT00952133 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Palonosetron only is the first listed.
NCT00952133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00952133 about?
NCT00952133 is a clinical study titled "Efficacy of IV Palo With IV Dexamethasone vs IV Palo for Prevention of Immediate & Delayed PONV". The purpose of this study is to determine if subjects who receive Palonosetron plus Dexamethasone have less post-operative nausea and vomiting (PONV) than those who receive Palonosetron alone.
What is the current status of trial NCT00952133?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 118 participants. The study started on 2009-07. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00952133?
The interventions under investigation include: Palonosetron only (DRUG), Palonosetron with Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT00952133?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.